BRIEF-Antares Pharma says Teva Pharmaceutical concluded decentralized procedure registration process in Europe for teriparatide injection product
Dec 19 Antares Pharma Inc
* Antares pharma says teva pharmaceutical has concluded decentralized procedure registration process in europe for teriparatide injection product Source text for Eikon: Further company coverage:
PRESS DIGEST- New York Times business news - June 28
June 28 The following are the top stories on the New York Times business pages. Reuters has not verified these stories and does not vouch for their accuracy.